Information

The study of Rosen et al. (2016) reveals that broader use of Euflexxa could significantly increase quality-adjusted life years for knee osteoarthritis patients in

The FLEXX trial of Altman et al. (2009) demonstrates that Euflexxa significantly alleviates knee osteoarthritis (OA) pain, enhancing joint function and overall quality of

The 2019 Global Burden of Disease study shed light on osteoarthritis, a prevalent degenerative joint disease worldwide. The study found that 73% of those

Peck et al. (2021) conducted a comprehensive review revealing that osteoarthritis is the most prevalent form of arthritis, affecting over 54 million adults in

Ko et al. (2022) demonstrated that a single injection of cross-linked hyaluronic acid can effectively treat knee osteoarthritis for up to 52 weeks. This